Optimizing decision-making process of benign uretero-enteric anastomotic stricture treatment after radical cystectomy.


Journal

World journal of urology
ISSN: 1433-8726
Titre abrégé: World J Urol
Pays: Germany
ID NLM: 8307716

Informations de publication

Date de publication:
Mar 2023
Historique:
received: 16 12 2022
accepted: 14 01 2023
medline: 11 4 2023
pubmed: 2 2 2023
entrez: 1 2 2023
Statut: ppublish

Résumé

To identify preoperative predictors of endo-urological treatment (EUT) failure while promoting a new diagnostic and therapeutic pathway for benign uretero-enteric anastomosis stricture (UES) management after radical cystectomy (RC). We relied on a prospectively maintained database including 96 individuals (122 renal units) who developed a benign UES at our institution between 1990 and 2018. UES was classified into two different types according to morphology: FP1 (i.e., sharp or duckbill) and FP2 (i.e., flat or concave). EUT feasibility, success rate, as well as intra and postoperative complications were recorded. Uni- and multivariable logistic regression analysis (MVA) assessed for predictors of EUT failure. Overall, 78 (63.9%) and 32 (26.3%) cases were defined as FP1 and FP2, respectively. EUT was not feasible in 33 (27.1%) cases. After a median follow-up of 50 (IQR 5-240) months, successful treatment was reached only in 15/122 (12.3%) cases. EUT success rates raised when considering short (< 1 cm) (16.8%), FP1 morphology (16.7%) strictures, or the combination of these characteristics (22.4%). Overall, 5 (5.2%) cases had CD ≥ III complications. FP2 (OR: 1.91, 95%CI 1.21-5.31, p = 0.03) and stricture length ≥ 1 cm (OR: 9.08, 95%CI 2.09-65.71, p = 0.009) were associated with treatment failure at MVA. Endoscopic treatment for benign UES after RC is feasible but harbors a low success rate. Stricture length and radiological morphology of the stricture are related to endoscopic treatment failure. Surgeons should be aware of the stricture features during the preoperative decision-making process to choose the optimal candidate for endoscopic treatment.

Identifiants

pubmed: 36725730
doi: 10.1007/s00345-023-04298-y
pii: 10.1007/s00345-023-04298-y
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

733-738

Informations de copyright

© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Références

Anderson CB, Morgan TM, Kappa S, Moore D, Clark PE, Davis R et al (2013) Ureteroenteric anastomotic strictures after radical cystectomy-does operative approach matter? J Urol 189:541–547. https://doi.org/10.1016/J.JURO.2012.09.034
doi: 10.1016/J.JURO.2012.09.034 pubmed: 23260561
Tal R, Sivan B, Kedar D, Baniel J (2007) Management of benign ureteral strictures following radical cystectomy and urinary diversion for bladder cancer. J Urol 178:538–542. https://doi.org/10.1016/J.JURO.2007.03.142
doi: 10.1016/J.JURO.2007.03.142 pubmed: 17570422
Shah SH, Movassaghi K, Skinner D, Dalag L, Miranda G, Cai J et al (2015) Ureteroenteric strictures after open radical cystectomy and urinary diversion: the University of Southern California experience. Urology 86:87–91. https://doi.org/10.1016/J.UROLOGY.2015.03.014
doi: 10.1016/J.UROLOGY.2015.03.014 pubmed: 25987494
Large MC, Cohn JA, Kiriluk KJ, Dangle P, Richards KA, Smith ND et al (2013) The impact of running versus interrupted anastomosis on ureterointestinal stricture rate after radical cystectomy. J Urol 190:923–927. https://doi.org/10.1016/J.JURO.2013.02.091
doi: 10.1016/J.JURO.2013.02.091 pubmed: 23454159
Minervini R, Pagni R, Mariani C, Morelli A, Morelli G, Minervini A (2010) Effects on renal function of obstructive and nonobstructive dilatation of the upper urinary tract in ileal neobladders with refluxing ureteroenteric anastomoses. Eur J Surg Oncol 36:287–291. https://doi.org/10.1016/J.EJSO.2009.09.003
doi: 10.1016/J.EJSO.2009.09.003 pubmed: 19796914
Laven BA, O’Connor RC, Gerber GS, Steinberg GD (2003) Long-term results of endoureterotomy and open surgical revision for the management of ureteroenteric strictures after urinary diversion. J Urol 170:1226–1230. https://doi.org/10.1097/01.JU.0000086701.68756.8F
doi: 10.1097/01.JU.0000086701.68756.8F pubmed: 14501730
Milhoua PM, Miller NL, Cookson MS, Chang SS, Smith JA, Herrell SD (2009) Primary endoscopic management versus open revision of ureteroenteric anastomotic strictures after urinary diversion–single institution contemporary series. J Endourol 23:551–555. https://doi.org/10.1089/END.2008.0230
doi: 10.1089/END.2008.0230 pubmed: 19193136
Schöndorf D, Meierhans-Ruf S, Kiss B, Giannarini G, Thalmann GN, Studer UE et al (2013) Ureteroileal strictures after urinary diversion with an ileal segment-is there a place for endourological treatment at all? J Urol 190:585–590. https://doi.org/10.1016/J.JURO.2013.02.039
doi: 10.1016/J.JURO.2013.02.039 pubmed: 23454401
Territo A, Verri P, Uleri A et al (2022) Endourological treatment of uretero-enteric benign stricture after radical cystectomy and kidney transplant. Cent Eur J Urol. https://doi.org/10.5173/CEJU.2022.238
doi: 10.5173/CEJU.2022.238
Ahmed YE, Hussein AA, May PR, Ahmad B, Ali T, Durrani A et al (2017) Natural history, predictors and management of ureteroenteric strictures after robot assisted radical cystectomy. J Urol 198:567–574. https://doi.org/10.1016/J.JURO.2017.02.3339
doi: 10.1016/J.JURO.2017.02.3339 pubmed: 28257782
Touiti D, Gelet A, Deligne E, Fassi-Fehri H, Benrais H, Martin X et al (2002) Treatment of uretero-intestinal and ureterovesical strictures by Acucise® balloon catheter. Eur Urol 42:49–55. https://doi.org/10.1016/S0302-2838(02)00070-2
doi: 10.1016/S0302-2838(02)00070-2 pubmed: 12121730
Singal RK, Denstedt JD, Razvi HA, Chun SS (1997) Holmium:YAG laser endoureterotomy for treatment of ureteral stricture. Urology 50:875–880. https://doi.org/10.1016/S0090-4295(97)00511-6
doi: 10.1016/S0090-4295(97)00511-6 pubmed: 9426717
Emiliani E, Breda A (2015) Laser endoureterotomy and endopyelotomy: an update. World J Urol 33:583–587. https://doi.org/10.1007/S00345-014-1405-3
doi: 10.1007/S00345-014-1405-3 pubmed: 25246158
Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213. https://doi.org/10.1097/01.SLA.0000133083.54934.AE
doi: 10.1097/01.SLA.0000133083.54934.AE pubmed: 15273542 pmcid: 1360123
Van Son MJ, Lock MTWT, Peters M, van de Putte EEF, Meijer RP (2019) Treating benign ureteroenteric strictures: 27-year experience comparing endourological techniques with open surgical approach. World J Urol 37:1217–1223. https://doi.org/10.1007/S00345-018-2475-4
doi: 10.1007/S00345-018-2475-4 pubmed: 30232554

Auteurs

Josep M Gaya (JM)

Department of Urology, Fundació Puigvert, Autonomous University of Barcelona, Cartagena 340-350, 08025, Barcelona, Spain.

Angelo Territo (A)

Department of Urology, Fundació Puigvert, Autonomous University of Barcelona, Cartagena 340-350, 08025, Barcelona, Spain.

Giuseppe Basile (G)

Department of Urology, Fundació Puigvert, Autonomous University of Barcelona, Cartagena 340-350, 08025, Barcelona, Spain. g.basile0984@gmail.com.

Andrea Gallioli (A)

Department of Urology, Fundació Puigvert, Autonomous University of Barcelona, Cartagena 340-350, 08025, Barcelona, Spain.

Christian Martínez (C)

Department of Urology, Fundació Puigvert, Autonomous University of Barcelona, Cartagena 340-350, 08025, Barcelona, Spain.

Morena Turco (M)

Department of Urology, Fundació Puigvert, Autonomous University of Barcelona, Cartagena 340-350, 08025, Barcelona, Spain.

Michael Baboudjian (M)

Department of Urology, Fundació Puigvert, Autonomous University of Barcelona, Cartagena 340-350, 08025, Barcelona, Spain.

Paolo Verri (P)

Department of Urology, Fundació Puigvert, Autonomous University of Barcelona, Cartagena 340-350, 08025, Barcelona, Spain.

Alessandro Tedde (A)

Department of Urology, Fundació Puigvert, Autonomous University of Barcelona, Cartagena 340-350, 08025, Barcelona, Spain.

Alessandro Uleri (A)

Department of Urology, Fundació Puigvert, Autonomous University of Barcelona, Cartagena 340-350, 08025, Barcelona, Spain.

Iacopo Meneghetti (I)

Department of Urology, Fundació Puigvert, Autonomous University of Barcelona, Cartagena 340-350, 08025, Barcelona, Spain.

Jordi Huguet (J)

Department of Urology, Fundació Puigvert, Autonomous University of Barcelona, Cartagena 340-350, 08025, Barcelona, Spain.

Antonio Rosales (A)

Department of Urology, Fundació Puigvert, Autonomous University of Barcelona, Cartagena 340-350, 08025, Barcelona, Spain.

Francesco Sanguedolce (F)

Department of Urology, Fundació Puigvert, Autonomous University of Barcelona, Cartagena 340-350, 08025, Barcelona, Spain.

Oscar Rodriguez-Faba (O)

Department of Urology, Fundació Puigvert, Autonomous University of Barcelona, Cartagena 340-350, 08025, Barcelona, Spain.

Joan Palou (J)

Department of Urology, Fundació Puigvert, Autonomous University of Barcelona, Cartagena 340-350, 08025, Barcelona, Spain.

Alberto Breda (A)

Department of Urology, Fundació Puigvert, Autonomous University of Barcelona, Cartagena 340-350, 08025, Barcelona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH